Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.7500 (-1.84%) ($7.6900 - $7.7500) on Wed. Apr. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.56% (three month average) | RSI | 32 | Latest Price | $7.7500(-1.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -8.3% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(47%) IBB(45%) ARKK(44%) ARKG(43%) XAR(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.28% in a week (0% probabilities). VIXM(-39%) VXX(-26%) UNG(-18%) USO(-11%) TLT(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.28% (StdDev 4.56%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.97(-177.03%) | Resistance Level | $8.86 | 5 Day Moving Average | $7.95(-2.52%) | 10 Day Moving Average | $8.33(-6.96%) | 20 Day Moving Average | $8.86(-12.53%) | To recent high | -50.5% | To recent low | 1% | Market Cap | $576m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |